Pacific Biosciences OF California, Inc.
USPTO PatentsView assignee record - 304 granted patents across 46 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Pacific ranks #1,381 of 49,997 tracked US assignees by granted-patent volume, with 304 patents across 46 technology areas.
- #1,381
- of 49,997 US assignees by volume
- Top 3%
- by Innovation Score (61.5/100)
- 20.4
- avg claims per patent
- -16%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R1381 · US Corporation #1,381 · 304 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 304 grants
- TOP-DECILE #1,381/49,997
- PHOTO-FINISH Avent
- CPC-WIDE C12Q · 46 areas
- INNOV-STRONG 61.5/100
- CLAIMS-DENSE 20.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -16% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Avent, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pacific’s 61.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pacific
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AyDeeKay · near
AyDeeKay · near
62 score
- Barco · near
Barco · near
62 score
- Beijing Jiaotong… · near
Beijing Jiaotong… · near
62 score
- Pacific Biosciences… · this assignee
Pacific Biosciences… · this assignee
62 score
- Yaskawa Denki · near
Yaskawa Denki · near
62 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pacific's Innovation Score is 61.5/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pacific?
Each dot is one of Pacific’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pacific’s own 20.4 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Pacific's grants concentrate
Pacific Biosciences OF California, Inc. is a focused PatentsView assignee: 46 CPC subclasses with 85.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (40 grants) versus a trough of 21 in 2022. By volume, Pacific sits between Yahoo Assets LLC and ELC Management LLC.
Pacific's three-year grant acceleration
From 2019–2021 to 2022–2024, Pacific Biosciences OF California, Inc. moved from 86 to 71 grants (0.83x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,737. See the growth leaderboard.
Who files at Pacific's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Yahoo Assets
Yahoo Assets LLC
305 patents
- Yandex Europe
Yandex Europe AG
305 patents
- Avent
Avent, Inc.
304 patents
- Keyence
Keyence Corporation
304 patents
- STC UNM
STC.UNM
304 patents
- Webasto SE
Webasto SE
304 patents
- Pacific Bioscienc… ◀
Pacific Biosciences OF California, Inc.
304 patents
- Deepmind
DeepMind Technologies Limited
303 patents
- ELC Management
ELC Management LLC
303 patents
What this shows Pacific holds 304 patents at rank #1,381, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pacific
By rank, the assignees closest to #1,381 in granted patent volume.
- Yahoo Assets LLC #1,377 · 305 patents
- Yandex Europe AG #1,378 · 305 patents
- Avent, Inc. #1,379 · 304 patents
- Keyence Corporation #1,380 · 304 patents
- STC.UNM #1,382 · 304 patents
- Webasto SE #1,383 · 304 patents
- DeepMind Technologies Limited #1,384 · 303 patents
- ELC Management LLC #1,385 · 303 patents
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in Pacific's primary technology class.
- The Regents of the University of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President and Fellows of Harvard College 387 in class
- Immatics Biotechnologies GmbH 286 in class
- 10x Genomics, Inc. 282 in class
- The Board of Trustees of the Leland Stanford Junior University 266 in class
- Gen-probe Incorporated 250 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Pacific, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Pacific ranks #8 of 2,502 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (62 here).
Similar claim depth
Nearest assignees by average claims per patent (20.4 here).
Pacific's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
62 Top 3% higher than 97% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 40 | 13.2% |
| 2016 | 25 | 8.2% |
| 2017 | 39 | 12.8% |
| 2018 | 30 | 9.9% |
| 2019 | 24 | 7.9% |
| 2020 | 37 | 12.2% |
| 2021 | 25 | 8.2% |
| 2022 | 21 | 6.9% |
| 2023 | 24 | 7.9% |
| 2024 | 26 | 8.6% |
| 2025partial year | 13 | 4.3% |
Which technologies does Pacific Biosciences OF California, Inc. patent most?
Top 15 of 46 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pacific Biosciences OF California, Inc.'s patent record in context - here's where to go next.
- Pacific Biosciences OF California, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 85.2% of its portfolio - see every assignee active in that class. Explore C12Q
- Ranked #1,381 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pacific Biosciences OF California, Inc. against Yahoo Assets LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 61.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.